Public Health Microbiology reference laboratories fulfil a critical role in providing overarching testing and surveillance for notifiable, emerging and important pathogens.
These duties require the laboratory to possess an extensive repertoire of validated assays and the ability to rapidly respond to novel threats and outbreaks. For these, among other reasons, the 'one stop shop' approach of whole genome sequencing (WGS) has been embraced by microbiology reference laboratories. The ability to replace multiple labour-intensive assays with a single technique of superior typeability and discrimination at an often competitive price, although not without its challenges, has already begun to change the workflow of Public Health reference laboratories.
Overseas laboratories such as Public Health England and the US Centers for Disease Control and Prevention (CDC) are exemplars of how WGS has replaced not only conventional molecular typing for the routine surveillance of pathogens but also phenotypic testing such as serotyping [1] [2] [3] . The US Food and Drug Administration (FDA) sequencing initiative, GenomeTrakr consists of a network of US and international laboratories performing real time sequencing on foodborne pathogens from food, environmental and human samples, with sequences being made available on the public NCBI database. This rapid and detailed genomic surveillance has already been highly successful in detecting more outbreaks than prior genotyping whilst restricting the number of cases associated with each outbreak (Figure 1 Genetic mutations conferring non-toxigenic status cannot be determined from the screening PCR. By applying WGS, PHM has been able to infer functionality in diphtheria toxin gene positive strains, to not only report the first NTTB isolates from cases tested in Australia but to also characterise the genetic mutations associated with these isolates 7 . This sequencing is now routinely performed with appropriate timeliness to contribute to the public health response to toxin gene positive cases.
The use of whole genome sequencing to predict antibiotic resistance is still in its infancy. Overall, correlation between the extrapolated genotype and phenotype is promising and the epidemiological information generated on genetic mechanisms is valuable 8, 9 . Reports suggest that inferring antibiotic resistance from genotype results in an overestimation of resistance, possibly due to the presence of silent genes or poorly understood mechanisms 9, 10 . Certainly, there is no doubt that phenotypic testing is still incredibly important and that a greater body of work is necessary and rapid turn-around time established before WGS inferred antimicrobial resistance will be suitable for standalone use in clinical decision-making.
The application of genomics in public health microbiology laboratories is probably best known for its convenience and perfor- That is, facilitating the appropriate antimicrobial management of gonorrhoea in an era of increasing resistance to prevent treatment failure, timely provision of an accurate diagnosis to inform appropriate treatment, and providing molecular insights to better understand gonococcal transmission (Table 1) .
Mitigating antimicrobial resistance
Neisseria gonorrhoeae has shown a remarkable capacity to become resistant to the antimicrobial agents employed to control it.
With an estimated 78 million new cases each year and the emer- In Focus
